comparemela.com

Latest Breaking News On - Advanced rcc - Page 1 : comparemela.com

Future Perspectives and Unmet Needs in Renal Cell Carcinoma

The expert panel provides key takeaways and closing thoughts on future perspectives and unmet needs in the treatment of renal cell carcinoma.

Advanced renal cell carcinomaUnmet needsRenal cellAdvanced rccRenal cell carcinomaFuture perspectivesKey takeaways

Nivolumab Plus Cabozantinib in Non–Clear Cell RCC

David A. Braun, MD, PhD, highlights recent data focused on nivolumab plus cabozantinib in patients with non–clear cell renal cell carcinoma.

Advanced renal cell carcinomaPlus cabozantinibClear cellAdvanced rccRenal cell carcinomaNon clear cell rccNon clear cell renal carcinoma

KEYNOTE-B61: Lenvatinib Plus Pembrolizumab in Non–Clear Cell RCC

Focusing on the KEYNOTE-B61 trial evaluating lenvatinib plus pembrolizumab in the first line, a panel of medical oncologists react to clinical trial data on combination regimens in non–clear cell renal cell carcinoma.

Advanced renal cell carcinomaLenvatinib plus pembrolizumabClear cellRenal cell carcinomaAdvanced rccNon clear cell rccNon clear cell renal carcinomaKeynote b61

Overview of Non–Clear Cell RCC

The expert panel gives an overview of non–clear cell renal cell carcinoma, highlighting disease subtypes and treatment approaches.

Advanced renal cell carcinomaClear cellRenal cell carcinomaAdvanced rccNon clear cell rccNon clear cell renal carcinomaPapillary rccTranslocation renal cell carcinoma

Dr Merchan on Key Data Supporting Pembrolizumab-Based Regimens in Advanced RCC

Jaime R. Merchán, MD, discusses the role of pembrolizumab plus axitinib or lenvatinib in previously untreated advanced renal cell carcinoma.

Jaimer merchDivision of medical oncologyDepartment of medicineClinical trials programUniversity of miami health systemSylvester comprehensive cancer centerClinical oncology research programMedical oncologyTrials programMiami health systemCancers symposiumAdvanced rcc

vimarsana © 2020. All Rights Reserved.